• Best stocks to buy now
  • Contact
  • Disclaimer
Friday, January 27, 2023
No Result
View All Result
  • ItalianoItaliano
Best Stocks
  • News
  • Best stocks to buy nowHOT
    Best Stocks To Buy Now 2022

    Best Stocks To Buy Now: January 26, 2023

    Best Stocks to buy now eyes pointed on GameStop, Chipotle and NetFlix

    Best Stocks To Buy Now: January 25, 2023

    HYB stock news

    Best Stocks To Buy Now: January 24, 2023

    Trending Tags

    • BABA
    • DIS
    • TSLA
    • SKLZ
    • NYSE: GME
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech Stocks
    • Utility Stocks
  • Data & Tools
    • Indices
    • Portfolio Tracker
    • Stock Quotes
    • Stock Targets
  • About us
Best Stocks
Home News

5 Stocks on the Dow To Buy and 3 Stocks To Avoid This August

The last three trading days of July saw the Dow Industrial Average rose to its highest point since early June.

by Ronald Kaufman
August 28, 2022
in Dow Jones Today, News
5 Stocks on the Dow to Buy and Keep an Eye on This August
23
SHARES
502
VIEWS
Share on FacebookShare on Twitter

Apple (AAPL), Chevron (CVX), Merck (MRK), Microsoft (MSFT), and UnitedHealth Group (UNH) are some of the finest Dow Jones companies to buy and keep an eye on this August (UNH). 

At the beginning of August, there are noticeable advantages and disadvantages. 

For example, through July 29, the best-performing Dow Jones equities were Chevron (CVX), Merck (MRK), and Amgen (AMGN), in that order.

Disney (DIS), Nike (NKE), and Intel (INTC) were the worst-performing Dow Jones equities through July 29, with year-to-date drops of 31.5%, 31.1%, and 29.5%, respectively.

The Nasdaq, heavily weighted toward technology, has fallen 20.8% year-to-date as of July. 

From their respective highs on May 21, the S&P was down 13.3%, and the Dow was down 9.6% as of July 29.

What Is the Dow Industrial Average (DJIA)? 

The DJIA is a historical index created in 1896 with the initial inclusion of only 12 firms. 

The 30 stocks that make up the Dow Jones are meant to be representative of the broader U.S. stock market. 

The Nasdaq composite, which focuses on technology, and the Standard & Poor’s 500 index, which tracks the performance of the 500 most giant U.S. corporations, are two other prominent stock market indices.

5 Most Anticipated Stocks on the Dow

IBD Big Picture analysts have advised investors to put their money into the strongest relative performers in the current stock market surge.

If the Dow Jones Industrial Average continues its recent uptrend, these stocks might be among the market’s leaders.

Apple, Chevron, Merck, Microsoft, and UnitedHealth are all Dow Jones companies to keep an eye on in August since they are in or near their respective buy zones.

Apple Inc 

IBD analysis shows that Apple stock dropped 3.2% on Friday despite the ongoing recovery and is now trading at around 10% below its 52-week high. 

As a result, 176.25 is a purchase point.

Apple stock has 92 out of 99 IBD Rating, per the results of an IBD Checkup. 

The IBD Rating is an effective tool for finding promising growth companies since it combines technical and fundamental indicators.

Chevron

The petroleum giant Chevron of the Dow is constructing the right side of a cup base with a buy price of 182.50. In addition, a short-term entry at 164.73 remains viable.

The share price of Chevron fell by 0.5% on Friday.

Merck

Drugmaker Merck has formed a new flat base with a 95.82 purchase point, although it is still approximately 7% away from the entrance.

Shares dropped 1% on Friday, extending their slide below the 50-day moving average.

Microsoft

Microsoft, the software market leader and a Dow component fell 3.1% on Friday and closed at its 50-day moving average.

Shares of MSFT have dropped almost 23% from their 52-week high. 

UnitedHealth Group

UnitedHealth, a major health insurance provider and company on the IBD Leaderboard fell 1.8% on Friday, putting it back inside buying range above the 518.80 purchase point of its double-bottom-with-handle base.

 

Tags: Apple Inc.Chevron Corp.Dow Jones TodayMerck & CoMerck stockMicrosoft Corpnasdaq compositeS&P 500S&P 500 StockS&P 500 todayUnitedHealth Group Inc
Ronald Kaufman

Ronald Kaufman

Ronald Kaufman is a veteran analyst and researcher with an expertise in the fields of Pharma, Cyber, FoodTech and Blockchain. He has been published on entrepreneur.com, GuruFocus, Finextra Research and others. He is currently a researcher at the Future Markets Research Tank (FMRT), where he does deep-dive market analysis and research in a number of industries.

DISCLAIMER

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

The Best Stocks, its managers, its employees, affiliates and assigns (collectively “The Company”) do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

READ MORE

Follow us on Social Media
Facebook – YouTube – Twitter

Write for us
Finance – Business

Best-Stocks-Logo_dark

Categories
Best Stocks to buy now
Crypto
Dow Jones Today
Pre-IPO and Startups
Tech stocks
Utility Stocks

Data and Tools
Quote
Target
Wealth
Converter
Dow Jones Today

Best Stocks to Buy Now

We are a financial media dedicated to providing stock recommendations, news, and real-time stock prices.

  • Disclaimer
  • Privacy Policy
  • Best stocks to buy now
  • Contact
  • Write for us – Finance, Crypto

© 2023 Best Stocks

No Result
View All Result
  • Home
  • News
  • Best stocks to buy now
  • Categories
    • Crypto
    • Dow Jones Today
    • Pre-IPO and Startups
    • Tech stocks
    • Utility Stocks
  • Data & Tools
    • Indices
    • Portfolio Tracker
    • Stock Quotes
    • Stock Targets
  • About us
  • English
  • Italiano

© 2023 Best Stocks